Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom

Socio-economic burden of rare diseases: A systematic review of cost of illness evidence

(2015) Aris Angelis et al.   HEALTH POLICY

Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis

(2013) Leonie A. Tepper et al.   EUROPEAN RESPIRATORY JOURNAL

Health-Related Quality of Life in Children and Adolescents with Cystic Fibrosis

(2013) Audrey Tluczek et al.   JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS

Understanding the Costs of Care for Cystic Fibrosis: An Analysis by Age and Health State

(2013) Kees van Gool et al.   VALUE IN HEALTH

Economic Burden of Non-Cystic Fibrosis Bronchiectasis in the First Year after Diagnosis from A US Health Plan Perspective

(2013) Vijay N. Joish et al.   Applied Health Economics and Health Policy

Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study

(2012) Renata Linertová et al.   HEALTH POLICY

Cost of Illness of Cystic Fibrosis in Germany

(2012) Mareike Heimeshoff et al.   PHARMACOECONOMICS

Health-related quality of life of Spanish children with cystic fibrosis

(2012) Iris F. Groeneveld et al.   QUALITY OF LIFE RESEARCH

Resource Use, Costs, and Utility Estimates for Patients with Cystic Fibrosis with Mild Impairment in Lung Function: Analysis of Data Collected Alongside a 48-Week Multicenter Clinical Trial

(2012) Esi Morgan DeWitt et al.   VALUE IN HEALTH

Medikamentöse Behandlung von Mukoviszidose – Kostenstruktur und Einsparpotenzial der ambulanten Behandlung

(2011) Christoph T. H. Baltin et al.   MEDIZINISCHE KLINIK

PGD for all cystic fibrosis carrier couples: novel strategy for preventive medicine and cost analysis

(2010) I. Tur-Kaspa et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Trends in bronchiectasis mortality in England and Wales

(2010) Helen J. Roberts et al.   RESPIRATORY MEDICINE

Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany

(2009) Daniela Eidt-Koch et al.   BMC Pediatrics

Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature

(2008) Jennifer R Weiner et al.   EXPERT OPINION ON PHARMACOTHERAPY

Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network

(2008) Laure Huot et al.   Journal of Cystic Fibrosis